Patents by Inventor RAMESH CHINGLE

RAMESH CHINGLE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Synthetic cyclic peptide mimetics
    Patent number: 12616760
    Abstract: Described herein are synthetic cyclic peptide mimetics comprising alternating D-amino acids and L-amino acids and amino acid derivatives, such as aza-amino acids and azasulfuryl-amino acids. Optionally, the cyclic peptide mimetics may be conjugated to another agent via a linker to form cyclic peptide mimetic conjugates. The cyclic peptide mimetics described herein may be used as diagnostic or therapeutic agents for diagnosis or treatment of amyloidogenic diseases.
    Type: Grant
    Filed: September 13, 2021
    Date of Patent: May 5, 2026
    Assignees: BAR ILAN UNIVERSITY, UNIVERSITÉ DE MONTRÉAL, SOCIÉTÉ DE COMMERCIALISATION DES PRODUITS DE LA RECHERCHE APPLIQUÉE SOCPRA SCIENCES SANTÉ ET HUMAINES S.E.C.
    Inventors: Shai Rahimipour, Maram Habashi, Michal Richman, William Lubell, Pradeep Chauhan, Suresh Vutla, Ramesh Chingle, Samia Ait-Mohand, Veronique Dumulon-Perreault, Brigitte Guerin
  • SYNTHETIC CYCLIC PEPTIDE MIMETICS
    Publication number: 20240316225
    Abstract: Described herein are synthetic cyclic peptide mimetics comprising alternating D-amino acids and L-amino acids and amino acid derivatives, such as aza-amino acids and azasulfuryl-amino acids. Optionally, the cyclic peptide mimetics may be conjugated to another agent via a linker to form cyclic peptide mimetic conjugates. The cyclic peptide mimetics described herein may be used as diagnostic or therapeutic agents for diagnosis or treatment of amyloidogenic diseases.
    Type: Application
    Filed: September 13, 2021
    Publication date: September 26, 2024
    Applicants: BAR ILAN UNIVERSITY, UNIVERSITÉ DE MONTRÉAL, SOCIETE DE COMMERCIALISATION DES PRODUITS DE LA RECHERCHE APPLIQUEE SOCPRA SCI
    Inventors: Shai RAHIMPOUR, Maram HABASHI, Michal RICHMAN, William LUBELL, Pradeep CHAUHAN, Suresh VUTLA, Ramesh CHINGLE, Samia AIT-MOHAND, Veronique DUMULON-PERREAULT, Brigitte GUERIN
  • Cyclic peptides and uses thereof
    Patent number: 11879021
    Abstract: Novel cyclic peptide GHRP-6 analogs of formula (I): (I) or pharmaceutically acceptable esters or salts thereof, are described. These cyclic peptide GHRP-6 analogs may be used for modulating CD36 activity, for example for the treatment of CD36-related diseases, disorders or conditions in a subject, such as atherosclerosis and age-related macular degeneration.
    Type: Grant
    Filed: June 28, 2017
    Date of Patent: January 23, 2024
    Inventors: William D. Lubell, Huy Ong, Jinqiang Zhang, Dilan Mukandila Mulumba, Sylvie Marleau, Ragnhild Gaard Ohm, Ahsanullah, Samy Omri, Ramesh Chingle
  • NOVEL CYCLIC PEPTIDES AND USES THEREOF
    Publication number: 20190202863
    Abstract: Novel cyclic peptide GHRP-6 analogs of formula (I): (I) or pharmaceutically acceptable esters or salts thereof, are described. These cyclic peptide GHRP-6 analogs may be used for modulating CD36 activity, for example for the treatment of CD36-related diseases, disorders or conditions in a subject, such as atherosclerosis and age-related macular degeneration.
    Type: Application
    Filed: June 28, 2017
    Publication date: July 4, 2019
    Inventors: WILLIAM D. LUBELL, HUY ONG, JINQIANG ZHANG, DILAN MUKANDILA MULUMBA, SYLVIE MARLEAU, RAGNHILD GAARD OHM, AHSANULLAH, SAMY OMRI, RAMESH CHINGLE